Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the newspaper advertisement of the Audited Financial Results ....

30 July 2026 Listing Department, BSE Limited Department of Corporate Services, P.J Towers, Dalal Street, Mumbai- 400 001 Script Code: 526544 ISIN: INE967B01028 Sub: Newspaper Publication of Audited Financial Results Dear Sir/Madam Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the newspaper advertisement of the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026, published on July 29, 2026 in Financial Express (English and Gujarati). Kindly take note of the same in your records. For, SGL RESOURCES LIMITED Kantilal Ladani Whole Time Director and CFO (DIN: 00016171) Encl.: As Above CIN:L22219GJ1992PLC017073 Registered and Corporate Office :- 506, [P]:- +91 9879933230 Fifth Floor, Venus Atlantis, Near Shell Petrol [E]hello@sgligis.com Pump, Prahalad Nagar Road, Ahmedabad, www.sgligis.com Gujarat, India, 380015 SGL R esources L imited CIN: L62013GJ1992PLC017073 Regd Office - 506, 5th Floor, Venus Atlantis, Near Shell Petrol Pump, Prahalad Nagar Road, Anand Nagar Road, Ahmedabad, Gujarat - 380015 Email - cs@sgligis.com | Phone No: 079 49391735 | Web: www.sgligis.com STATEMENT OF AUDITED FINANCIAL RESULTS (STANDALONE & CONSOLIDATED) FOR THE QUARTER AND YEAR ENDED ON MARCH 31, 2026 The Board of Directors of the Company, at the meeting held on Monday, July 27, 2026 approved the Audited Financial Results (Standalone and Consolidated ) of the Company for the Quarter and Year Ended March 31, 2026. The Full format of Financial Results, along with the Auditor's Limited Review Report have been posted on the Company's website at https://www.sgligis.com/wp-content/uploads/Outcome- merged-output.pdf and are available on the stock exchange website i.e. www.bseindia.com. The same can be accessed by scanning the given OR code. Place: Ahmedabad For SGL Resources Limited Date: July 28, 2026 Sd/- Mr. Kantilal Ladani - Whole-Time Director & CFO -DIN: 00016171 The above mentioned intimation is in accordance with Regulation 33 read with Regulation 47(1) of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 JUBILANT PHARMOVA LIMITED (CIN: L24116UP1978PLC004624) Registered Office: Bhartiagram, Gajraula, District Amroha - 244223, Uttar Pradesh, India Website: www.jubilantpharmova.com Email: investors@jubl.com Phone: +91-5924-267437 INFORMATION REGARDING 48TH ANNUAL GENERAL MEETING OF JUBILANT PHARMOVA LIMITED, RECORD DATE AND DIVIDEND INFORMATION Notice is hereby given that the Forty-Eighth (48th) Annual General Meeting (‘AGM’) of the Members of Jubilant Pharmova Limited (‘Company’) will be held on Wednesday, August 26, 2026 at 11:00 A.M. (IST) through Video Conferencing (‘VC’)/ Other Audio Visual Means (‘OAVM’) in compliance with applicable provisions of the Companies Act, 2013, (‘Act’) and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘Listing Regulations’) and circulars issued thereunder, to transact the business(es) as set forth in the Notice of AGM. Members attending the AGM through VC / OAVM shall be reckoned for the purpose of quorum under Section 103 of the Act. In accordance with the Circulars issued, the Notice of AGM and the Financial Statements for the Financial Year 2025-26 along with Reports of the Board of Directors and the Auditors and other documents required to be attached thereto (collectively referred as ‘Annual Report’) will be sent only through electronic mode to those Members whose email addresses are registered with the Company/ Depository Participants (DPs) or Registrar and Transfer Agent. Additionally, in accordance with Regulation 36(1)(b) of the Listing Regulations, the Company will also be sending a letter providing the web-link, including the exact path of the Annual Report to those members whose email address is not registered with the Company/DPs. The aforesaid documents will also be available on the website of the Company at www.jubilantpharmova.com and at the websites of the Stock Exchanges, i.e. BSE Limited www.bseindia.com and National Stock Exchange of India Limited www.nseindia.com. Further, members can join and participate in the AGM through VC/ OAVM facility only. The instructions for joining and manner of participation in the AGM have been provided in the Notice of the AGM. Process for registration of E-mail IDs is given below for those shareholders whose E-mail IDs are not registered: a) In case shares are held in physical mode, please provide Folio No., Name of shareholder, scanned copy of the share certificate (front and back), PAN (self-attested scanned copy of PAN card), AADHAAR (self-attested scanned copy of Aadhaar Card) by email to investors@jubl.com or rta@alankit.com. b) In case shares are held in demat mode, please provide DPID-CLID (16-digit DPID + CLID or 16-digit beneficiary ID), Name, client master or copy of Consolidated Account statement, PAN (self-attested scanned copy of PAN card), AADHAAR (self-attested scanned copy of Aadhaar Card) to investors@jubl.com or rta@alankit.com. The Company is providing remote e-voting facility to all its members to cast their votes on the resolutions set out in the Notice of the AGM. Additionally, the Company is also providing the facility of voting through e-voting system during the AGM. Detailed procedure for casting votes through remote e-voting/ e-voting has been provided in the Notice of the AGM. The Board of Directors of the Company has at its meeting held on May 22, 2026, recommended payment of dividend of Rs. 5/- (i.e. 500%) per Equity Share of face value of Re. 1/- each for the Financial Year ended March 31, 2026, subject to approval of Members at the AGM. The dividend, if approved by the Members, will be paid to the Members holding Equity Shares of the Company, either in electronic or in physical form as on the record date, i.e. July 24, 2026 for determining eligibility of Members to receive the dividend. Pursuant to the relevant provisions of the Income-tax Act, 2025, the Company will be required to withhold taxes at the prescribed rates on the dividend paid to its shareholders. The TDS rate may vary depending on the residential status of the shareholder and the documents submitted to the Company in accordance with the provisions of the Income Tax Act, 2025. Upon declaration, the dividend will be taxable in the hands of the shareholders in the FY 2026-27 (Assessment Year 2027-28). The rates of TDS applicable to various categories of shareholders along with the requisite documents are available on the website of the Company at www.jubilantpharmova.com. Please note that the aforesaid documents, duly executed, could be sent to the Company as under: (A) Executed documents can be sent through email investors@jubl.com; (B) Executed documents (in original) can be sent directly at the Corporate Office of the Company at Plot 1A, Sector 16A, Noida-201301, Uttar Pradesh. The aforesaid executed documents must reach the Company on or before August 14, 2026 in order to enable the Company to determine and deduct appropriate TDS / withholding tax on the payment of dividend. It is to be duly noted that Members sending documents through email are also required to send the executed documents (in original) at the Corporate Office of the Company. Members holding Equity Shares of the Company in demat form and who have not registered their Bank details are requested to approach their respective Depository Participant to register their Bank account details. The Members holding Equity Shares of the Company in physical form and who have not registered their Bank details may register their Bank details by sending email to investors@jubl.com or rta@alankit.com. For Jubilant Pharmova Limited Sd/- Naresh Kapoor Date: July 28, 2026 Company Secretary Place: Noida ACS No: A11782